CDC Lists Dozens of Infectious Disease Tests as Unavailable in Lab Directory
Thirty-one test orders are currently listed as unavailable, requiring labs to seek alternative testing pathways or coordinate with public health partners.
Thirty-one test orders are currently listed as unavailable, requiring labs to seek alternative testing pathways or coordinate with public health partners.
The FDA has granted Breakthrough Device Designation to MeMed BV Flex, an AI-powered capillary blood test designed to distinguish bacterial from viral infections in 15 minutes using host-response biomarkers.
Visby Medical and Watchmaker Genomics have partnered to develop at-home PCR respiratory tests designed to overcome molecular inhibitors found in unprocessed clinical samples, according to a joint announcement.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
From assay validation to staffing and supply chain planning, labs can take steps to manage testing surges during flu and RSV season.
The Liaison Plex Gastrointestinal Flex Assay detects 24 targets and offers broad parasite coverage with pay-per-target flexibility.
Monash University study finds different testing algorithms work best for pregnant women versus men who have sex with men.